SGK
CRL icon

Steigerwald Gordon & Koch’s Charles River Laboratories CRL Stock Holding History

Steigerwald Gordon & Koch’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Hold
19
– – ﹤0.01% 627
2026
Q1 		$3.28K Hold
19
– – ﹤0.01% 653
2025
Q4 		$3.79K Hold
19
– – ﹤0.01% 725
2025
Q3 		$2.97K Buy
+19
New +$3.02K ﹤0.01% 695

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Steigerwald Gordon & Koch's CRL Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Charles River Laboratories (CRL) position steady in Q2 2026 at 19 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Steigerwald Gordon & Koch first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Steigerwald Gordon & Koch held 19 shares of Charles River Laboratories worth $4.31K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #627 holding.
  • Steigerwald Gordon & Koch first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.